Duangdara, J.; Boonsri, B.; Sayinta, A.; Supradit, K.; Thintharua, P.; Kumkate, S.; Suriyonplengsaeng, C.; Larbcharoensub, N.; Mingphruedhi, S.; Rungsakulkij, N.;
et al. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals 2024, 17, 9.
https://doi.org/10.3390/ph17010009
AMA Style
Duangdara J, Boonsri B, Sayinta A, Supradit K, Thintharua P, Kumkate S, Suriyonplengsaeng C, Larbcharoensub N, Mingphruedhi S, Rungsakulkij N,
et al. CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals. 2024; 17(1):9.
https://doi.org/10.3390/ph17010009
Chicago/Turabian Style
Duangdara, Jinchutha, Boonyakorn Boonsri, Apinya Sayinta, Kittiya Supradit, Pakpoom Thintharua, Supeecha Kumkate, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Somkit Mingphruedhi, Narongsak Rungsakulkij,
and et al. 2024. "CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS" Pharmaceuticals 17, no. 1: 9.
https://doi.org/10.3390/ph17010009
APA Style
Duangdara, J., Boonsri, B., Sayinta, A., Supradit, K., Thintharua, P., Kumkate, S., Suriyonplengsaeng, C., Larbcharoensub, N., Mingphruedhi, S., Rungsakulkij, N., Muangkaew, P., Tangtawee, P., Vassanasiri, W., Suragul, W., Janvilisri, T., Tohtong, R., Bates, D. O., & Wongprasert, K.
(2024). CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini-Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS. Pharmaceuticals, 17(1), 9.
https://doi.org/10.3390/ph17010009
